Telefónica launches tele-rehabilitation solution
Telefonica, the third largest telecommunications provider in the world, and the leading provider in Spain and Latin America, has launched its much anticipated ‘Rehabitic’ product.
Rehabatic uses wearable wireless sensing technology from Shimmer Research and is designed for patients who have had a total knee replacement and need extensive physiotherapy.
The innovative new product also enables the rehabilitation regime to be carried out in the comfort of the patient’s own home while maintaining the oversight of clinicians who monitor session from the hospital.
To read the latest edition of Healthcare Global, click here
- Lack of sleep and disrupted body clock damages immunity
- Heart attack scars can be healed with stem cells
- Valentine’s Day campaign urges smokers to quit
To use Rehabatic, the patient attaches Shimmer devices to both sides of the affected knee in front of a touch screen PC.
Application software then visually instructs them through their prescribed therapy session.
An onscreen avatar displays the patient’s movement in real-time, with dynamic feedback and reflection of performance.
All the collected information is then sent to the clinician for either real time or offline assessment.
Tested in Grenada, Spain and Chile, results have been highly effective in this promising market for tele rehabilitation.
Shimmer Research has been a leader in wearable wireless sensing since its founding in 2008.
The company designs, develops and manufactures a full range of wearable Kinematic, BioPhysical and Ambient sensing modules and solutions, currently used in over 50 countries for a wide variety of applications.
The company’s core product, the Shimmer, is a wireless sensor platform that allows for the capture and communication of a sensed data in real-time, featuring low-power, standards based, wireless communication technologies and a large storage capacity which facilitates wearable wireless sensing in both connected and offline modes.
The Healthcare Global magazine is now available on the iPad. Click here to download it.
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”